Cite
HARVARD Citation
Lenz, G. et al. (n.d.). CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. Hematological oncology. pp. 68-69. [Online].